Back
Zoetis Inc. (ZTS)
PharmaceuticalsZTS · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$77.73
+3.61%Weekly undervalued picks (like ZTS)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$6.02
ROE
67.7%
Gross margin
71.8%
Debt/Equity
2.86x
Revenue growth
2.9%
Zoetis Inc. — company intelligence
Earnings surprises
Q2 2026$1.87 vs $1.87 est-0.2%
Q1 2026$1.53 vs $1.63 est-6.2%
Q4 2025$1.48 vs $1.42 est+4.5%
Q3 2025$1.70 vs $1.64 est+3.8%
Analyst consensus · 24 analysts
13 Buy11 Hold0 Sell
Updated Jul 27, 2026
Insider activity · 90 days
10 buys0 sellsnet +2,993 shares
Driscoll RimmaBuy 238 · Jul 10, 2026
Esch KevinBuy 308 · Jul 10, 2026
Ferran Astorga JeannetteBuy 45 · Jul 10, 2026
Recent SEC filings
4 — Insider transaction reportAug 11, 2026
8-K — Material event reportAug 6, 2026
10-Q — Quarterly reportAug 6, 2026
Latest news
Zoetis Stock: Is Wall Street Bullish or Bearish? — Yahoo · 2w ago
Piper Sandler Maintains Neutral on Zoetis, Lowers Price Target to $80 — Benzinga · 2w ago
Zoetis (ZTS) Looked Like a Winner. What Went Wrong? — Yahoo · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like ZTS)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.